Position in NGNE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$13,838
-$11,946 QoQ
Shares Held
440
-65.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 112 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. NGNE ranks #287 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in NGNE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,838 | 440 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $25,784 | 1,279 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,399 | 1,233 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,224 | 1,167 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,644 | 1,916 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $7,845 | 670 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,378 | 629 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $352,295 | 8,396 | Shares | Other | 2024-11-14 | |
| 2023-09-30 NLTX | — | 823 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||